FTC counsel takes measured stance on refusals to deal

Pallavi Guniganti

31 March 2014

Tracleer is one of the medications that Actelion refused to sell to generic rivals.

Subscribe to Global Competition Review

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

View full biography

Author

[email protected]

Home is where the enforcement is: The Tipline for 27 March 2023
Big Tech might garner most of the headlines, but the US antitrust enforcers are certainly keeping an eye on the homebuying industry. Earlier this month, the Federal Trade Commission sued to block Intercontinental Exchange’s acquisition of Black Knight over competitive concerns related to mortgage loan software. Now, the Department of Justice is challenging a ruling from earlier this year that prevented it from reopening an investigation into the National Association of Realtors. Also in …
Words without thoughts: The Tipline for 24 March 2023
Labour is painful: The Tipline for 23 March 2023